INTERSECT SYSTEMS TRIGLYCERIDE-GPO REAGENT— 510(k) K870827

Name: FDA 510(k) clearance K870827
Creator: U.S. Food and Drug Administration
Published: 1987-03-13

Substantially Equivalent

Intersect Systems, Inc.

FDA 510(k) clearance K870827 for INTERSECT SYSTEMS TRIGLYCERIDE-GPO REAGENT, Substantially Equivalent on 1987-03-13. Applicant: Intersect Systems, Inc.. Device class: 1.

Clearance details

Applicant: Intersect Systems, Inc.
Product code: Code CDT
Device class: Class 1
Regulation: 21 CFR 862.1705
Advisory panel: Clinical Chemistry
Date received: 1987-03-03
Decision date: 1987-03-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Longview, WA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CDT

view all

K150819 — Triglycerides2015-08-06
K133067 — ADVIA CHEMISTRY TRIGLYCERIDES_2 (TRIG_2) REAGENT2013-11-22
K130332 — VITROS CHEMISTRY PRODUCTS TRIG SLIDES2013-05-31
K113830 — VANTERA CLINICAL ANALYZER2012-08-30
K102993 — ELITECH CLINICAL SYSTEMS TRIGLYCERIDES SL, ELITECH CLINICAL SYSTEMS CHOLESTEROL SL2011-05-19

More clearances from Intersect Systems, Inc.

view all

K021636 — ALBUMIN REAGENT2002-07-17
K011972 — DIRECT BILIRUBIN REAGENT2001-08-27
K011692 — HOMOGENEOUS ENZYMIC HOMOCYSTEINE REAGENT2001-07-25
K003892 — TOTAL BILIRUBIN REAGENT2001-02-20
K983937 — DUAL VIAL CREATININE REAGENT1999-01-06

Data sourced from openFDA. This site is unofficial and independent of the FDA.